Free Trial
ASX:CPH

Creso Pharma (CPH) Stock Price, News & Analysis

Creso Pharma logo

About Creso Pharma Stock (ASX:CPH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$23.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Receive CPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creso Pharma and its competitors with MarketBeat's FREE daily newsletter.

CPH Stock News Headlines

Cipher Pharmaceuticals Announces Q3 2024 Financial Results
“You all just got a lot richer”
Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crashes. Do you think that’s an accident? When he threatens to “End the Fed” do you think he doesn’t know banking stocks will benefit? What about when he tells his followers, “Now is a good time to buy,” hours before relaxing tariffs and sending the market soaring? Is that an accident? Larry Benedict doesn’t think so. He thinks Trump knows what he’s doing… and believes he’s found the perfect tickers for everyday Americans to take advantage next time he triggers a big move.
See More Headlines

CPH Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Creso Pharma investors own include Evolution Mining (EVN), Skin Elements (SKN), Santos (STO), Aurizon (AZJ), C29 Metals (C29), CIMIC Group (CIM) and CSL (CSL).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:CPH
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.78 million
Net Margins
-377.28%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.92 million
Price / Cash Flow
N/A
Book Value
A$0.02 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,570,000,000
Free Float
N/A
Market Cap
$23.11 million
Optionable
Not Optionable
Beta
2.62
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (ASX:CPH) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners